恶化性心力衰竭:命名、流行病学与未来方向
本文系统回顾了恶化性心力衰竭(WHF)定义的演变,从仅关注住院事件扩展至包括非住院事件(如急诊或门诊静脉利尿剂需求)。文章强调WHF发作标志着心衰进入新阶段,总结了相关新型疗法的临床试验,并指出WHF识别与治疗中未满足的需求。
要点
- WHF定义已从仅住院扩展至非住院事件,如急诊或门诊静脉利尿剂治疗。
- WHF发作应被视为心衰病程中的一个新阶段,而不仅是孤立事件。
- 现有心衰试验多以住院和死亡为主要终点,近期部分研究纳入非住院WHF事件。
核心结论
- WHF是心衰病程中尽管持续治疗仍出现的临床恶化阶段,其定义正从住院事件扩展至非住院事件。
研究设计与样本
- 本文为JACC综述,回顾WHF定义演变、流行病学特征、相关临床试验及未满足需求。
主要发现
- WHF定义从历史仅关注住院,演变为包括非住院事件如急诊或门诊静脉利尿剂需求。
- 多数心衰临床试验以心衰住院和死亡为主要终点,近期部分研究纳入其他WHF事件 regardless of care location。
临床怎么用
- 临床应关注WHF的非住院表现,如急诊或门诊静脉利尿剂使用,将其视为心衰进入新阶段的标志。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heart failure (HF) is a progressive disease characterized by variable durations of symptomatic stability often punctuated by episodes of worsening despite continued therapy. These periods of clinical worsening are increasingly recognized as a distinct phase in the history of HF, termed worsening HF (WHF). The definition of WHF continues to evolve from a historical focus solely on hospitalization to now include nonhospitalization events (eg, need for intravenous diuretic therapy in the emergency or outpatient setting). Most HF clinical trials to date have had HF hospitalization and death as primary endpoints, and only recently, some studies have included other WHF events regardless of location of care. This article reviews the evolution of the WHF definition, highlights the importance of considering the onset of WHF as an event that marks a new phase of HF, summarizes the latest clinical trials investigating novel therapies, and outlines unmet needs regarding identification and treatment of WHF.
引用
- Greene, Bauersachs, Brugts, et al. Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. J Am Coll Cardiol. 2023. PMID: 36697141. doi:10.1016/j.jacc.2022.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。